Novo Nordisk A/S ADR buy BTIG Research
Start price
29.03.23
/
50%
€144.50
Target price
29.03.24
€28.58
Performance (%)
-16.96%
End price
30.03.24
€120.00
Summary
This prediction ended on 30.03.24 with a price of €120.00. The prediction for Novo Nordisk A/S ADR disappointed with a performance of -16.96%. Dividends of €1.43 are taken into consideration when calculating the performance. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 0.965% | 0.965% | -37.290% |
| iShares Core DAX® | 1.130% | 2.184% | 15.737% |
| iShares Nasdaq 100 | 1.128% | -0.611% | 7.324% |
| iShares Nikkei 225® | 2.610% | 4.958% | 20.446% |
| iShares S&P 500 | -0.006% | -0.952% | 2.166% |
Comments by BTIG_Research for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at BTIG Research from $20.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten